Ex-Roche Chairman Franz Humer committed the parent company to sustaining Genentech's "innovative culture", and his successor, Severin Schwann, has stated that he intends to "keep the two respective research and early development organizations as independent units"; merging the two R&D tech. Schwann needs suggestions on how best to follow through on both Humer's commitment and his own. It is no surprise that your boss has asked you to furnish her with two or three ideas that she might pass on the CEO. What will your suggestions be?